Xu, Z., Xu, S., Liu, X., Weng, P., Song, Q., Guo, G., Cai, B., Yu, Z., Zheng, H., Li, N. (2025). Blinatumomab combined with low-dose chemotherapy and TKI as first-line induction for newly diagnosed ph+ b-ALL: Improved efficacy and reduced toxicity. Blood. https://doi.org/10.1182/blood-2025-5130